Get the Stockscreener App
1.62
0.61%
-0.010
After Hours:
1.60
-0.02
-1.23%
Calidi Biotherapeutics Inc stock is traded at $1.62, with a volume of 152.58K.
It is down -0.61% in the last 24 hours and down -69.38% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$1.63
Open:
$1.61
24h Volume:
152.58K
Relative Volume:
0.10
Market Cap:
$8.61M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-2.1987
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
+1.25%
1M Performance:
-69.38%
6M Performance:
-83.04%
1Y Performance:
-88.36%
1-Day Range:
$1.59
$1.6395
1-Week Range:
$1.56
$1.6799
52-Week Range:
$1.51
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.62 | 8.61M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
Calidi prices 1.47M units at $2.00 in underwritten public offering - MSN
Is Calidi Biotherapeutics Inc. forming a bullish divergence2025 Bull vs Bear & Verified Chart Pattern Trade Signals - Lancaster City Council
Sector Leaders Rotate Capital Into Calidi Biotherapeutics Inc.2025 Key Lessons & Consistent Profit Trading Strategies - beatles.ru
Calidi Biotherapeutics Inc.’s Price Action Aligns with Quant SignalsJuly 2025 Final Week & Reliable Price Action Trade Plans - beatles.ru
Short Term Trend Reversal in Calidi Biotherapeutics Inc. PossibleJuly 2025 Decliners & Proven Capital Preservation Tips - beatles.ru
Can Calidi Biotherapeutics Inc. Regain Momentum After BreakdownJuly 2025 Technicals & Technical Confirmation Trade Alerts - beatles.ru
Calidi Biotherapeutics Inc. stock chart pattern explainedMarket Movement Recap & High Accuracy Buy Signal Tips - Newser
Is Calidi Biotherapeutics Inc. benefiting from interest rate changesJuly 2025 Reactions & Weekly High Conviction Trade Ideas - خودرو بانک
Can Calidi Biotherapeutics Inc. stock outperform in a bear marketTrend Reversal & Capital Efficient Trade Techniques - خودرو بانک
How cyclical is Calidi Biotherapeutics Inc.’s revenue streamWeekly Risk Summary & AI Powered Trade Plan Recommendations - خودرو بانک
Real time social sentiment graph for Calidi Biotherapeutics Inc.2025 Technical Overview & Technical Pattern Alert System - Newser
How high can Calidi Biotherapeutics Inc. stock go2025 Stock Rankings & Reliable Trade Execution Plans - Newser
What to do if you’re stuck in Calidi Biotherapeutics Inc.Earnings Overview Report & Real-Time Buy Zone Alerts - Newser
Has Calidi Biotherapeutics Inc. formed a bullish divergencePortfolio Risk Summary & Technical Entry and Exit Alerts - Newser
Using economic indicators to assess Calidi Biotherapeutics Inc. potentialWeekly Volume Report & Target Return Focused Picks - Newser
Real time scanner hits for Calidi Biotherapeutics Inc. explainedTrade Analysis Report & Weekly Momentum Picks - Newser
Does Calidi Biotherapeutics Inc. show high probability of reboundM&A Rumor & Consistent Growth Stock Picks - Newser
Is Calidi Biotherapeutics Inc. stock poised for growthJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Can Calidi Biotherapeutics Inc. generate free cash flow2025 Biggest Moves & Technical Entry and Exit Tips - خودرو بانک
Understanding Calidi Biotherapeutics Inc.’s price movementQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
Published on: 2025-09-04 08:54:30 - Newser
What does recent volatility data suggest for Calidi Biotherapeutics Inc.2025 AllTime Highs & Low Risk Growth Stock Ideas - Newser
Is Calidi Biotherapeutics Inc. stock a falling knife or bargain buyJuly 2025 Selloffs & Weekly Setup with ROI Potential - khodrobank.com
Analyzing net buyer seller activity in Calidi Biotherapeutics Inc.Forecast Cut & AI Enhanced Trade Execution Alerts - Newser
Jobs Data: Is Calidi Biotherapeutics Inc. trading at a discountJobs Report & Weekly Setup with High ROI Potential - خودرو بانک
Chart based analysis of Calidi Biotherapeutics Inc. trendsJuly 2025 WrapUp & Fast Gain Stock Tips - Newser
Calidi Biotherapeutics Inc. stock prediction for this week2025 Volume Leaders & Weekly Momentum Picks - Newser
What analysts say about Calidi Biotherapeutics Inc. stock2025 Pullback Review & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Will earnings trigger a reversal in Calidi Biotherapeutics Inc.Market Trend Review & Technical Buy Zone Confirmations - Newser
How to read the order book for Calidi Biotherapeutics Inc.Risk Management & Weekly High Conviction Ideas - Newser
Is Calidi Biotherapeutics Inc. reversing from oversold territoryWeekly Market Report & Reliable Price Breakout Alerts - Newser
What institutional flow reveals about Calidi Biotherapeutics Inc.Stock Surge & Stock Portfolio Risk Control - Newser
Calidi Biotherapeutics Inc. Stock Poised for Technical Comeback2025 Trade Ideas & Long-Term Growth Portfolio Plans - beatles.ru
Will Calidi Biotherapeutics Inc. stock recover after earningsWeekly Profit Report & Free Community Consensus Stock Picks - خودرو بانک
Calidi Biotherapeutics to Showcase RedTail Platform at H.C. Wainwright Global Investment Conference - citybuzz -
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Calidi Biotherapeutics to present at H.C. Wainwright Global Investment Conference. - AInvest
Revolutionary Cancer Gene Therapy: Calidi Bio to Present RedTail Platform for Metastatic Treatment - Stock Titan
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Florida Times-Union
Can Calidi Biotherapeutics Inc. navigate macro headwinds2025 Trading Volume Trends & Accurate Buy Signal Notifications - خودرو بانک
Is Calidi Biotherapeutics Inc. building a consolidation base2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
Will earnings trigger a reversal in Calidi Biotherapeutics Inc2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
Candlestick signals on Calidi Biotherapeutics Inc. stock todayJuly 2025 Institutional & Accurate Technical Buy Alerts - Newser
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Cap:
|
Volume (24h):